Anti tubercular drug: compositions and methods

US7456222B2 · kind B2 · utility

Assignees

• Sequella, Inc. · US
• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• Marina Protopopova · Silver Spring, US
• Richard E. Lee · Cordova, US
• Richard Slayden · Fort Collins, US
• Clifton E. Barry, III · Hamilton, US
• Elena Bogatcheva · Bethesda, US
• Leo Einck · McLean, US

Key dates

• Filing date: Jul 1, 2005
• Grant date: Nov 25, 2008
• Expiry date: Aug 25, 2025

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.